GIP and type 2 diabetes mellitus: New therapies involving incretin hormones are emerging, such as combinations of GLP‐1‐RA and GIP or even with glucagon.(105, 106, 107) Consequently, the modern‐day treatment approach utilizing incretin hormones for both weight loss and T2D is still in its early stages.